|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
34,000,000 |
Market
Cap: |
N/A |
Last
Volume: |
18,050 |
Avg
Vol: |
18,000 |
52
Week Range: |
$238.6 - $238.6 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Ohmstede Carol |
|
|
2007-05-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,400 |
|
- |
|
Bonczek Robert R |
CFO and General Counsel |
|
2007-02-28 |
4 |
OE |
$0.34 |
$1,200 |
D/D |
3,530 |
28,884 |
|
- |
|
Baker Felix |
Director |
|
2007-01-31 |
4 |
D |
$0.00 |
$0 |
I/I |
(14,779) |
316,360 |
|
- |
|
Baker Felix |
Director |
|
2006-10-02 |
4 |
D |
$0.00 |
$0 |
I/I |
(126,415) |
160,420 |
|
- |
|
Baker Felix |
Director |
|
2006-04-25 |
4 |
A |
$0.00 |
$0 |
I/I |
1,228,857 |
1,228,857 |
|
- |
|
Baker Felix |
Director |
|
2006-04-25 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,228,857) |
0 |
|
- |
|
Bolognesi Dani P |
Chief Scientific Officer |
|
2006-03-17 |
4 |
D |
$13.53 |
$96,780 |
I/I |
(7,153) |
9,000 |
|
- |
|
Bolognesi Dani P |
Chief Scientific Officer |
|
2006-03-17 |
4 |
OE |
$0.34 |
$2,432 |
I/I |
7,153 |
16,153 |
|
- |
|
Bolognesi Dani P |
Chief Scientific Officer |
|
2006-02-22 |
4 |
AS |
$12.00 |
$24,108 |
D/D |
(2,009) |
47,716 |
|
- |
|
Bolognesi Dani P |
Chief Scientific Officer |
|
2006-02-22 |
4 |
OE |
$0.34 |
$683 |
D/D |
2,009 |
49,725 |
|
- |
|
Bolognesi Dani P |
officerTitle |
|
2006-01-25 |
4 |
AS |
$11.30 |
$34,578 |
D/D |
(3,060) |
47,716 |
|
- |
|
Bolognesi Dani P |
officerTitle |
|
2006-01-25 |
4 |
OE |
$0.34 |
$1,040 |
D/D |
3,060 |
50,776 |
|
- |
|
Bolognesi Dani P |
officerTitle |
|
2005-12-22 |
4 |
AS |
$12.10 |
$37,026 |
D/D |
(3,060) |
47,716 |
|
- |
|
Bolognesi Dani P |
officerTitle |
|
2005-12-22 |
4 |
OE |
$0.34 |
$1,040 |
D/D |
3,060 |
50,776 |
|
- |
|
Crout J Richard |
officerTitle |
|
2005-12-08 |
4 |
B |
$12.00 |
$3,599 |
D/D |
300 |
4,300 |
2.31 |
- |
|
Bolognesi Dani P |
Chief Scientific Officer |
|
2005-11-21 |
4 |
AS |
$13.25 |
$40,545 |
D/D |
(3,060) |
47,472 |
|
- |
|
Bolognesi Dani P |
Chief Scientific Officer |
|
2005-11-21 |
4 |
OE |
$0.34 |
$1,040 |
D/D |
3,060 |
50,532 |
|
- |
|
Bolognesi Dani P |
Chief Scientific Officer |
|
2005-10-24 |
4 |
AS |
$14.00 |
$42,840 |
D/D |
(3,060) |
47,472 |
|
- |
|
Bolognesi Dani P |
Chief Scientific Officer |
|
2005-10-24 |
4 |
OE |
$0.34 |
$1,040 |
D/D |
3,060 |
50,532 |
|
- |
|
Bolognesi Dani P |
Chief Scientific Officer |
|
2005-09-14 |
4 |
AS |
$13.56 |
$41,494 |
D/D |
(3,060) |
47,472 |
|
- |
|
Bolognesi Dani P |
Chief Scientific Officer |
|
2005-09-14 |
4 |
OE |
$0.34 |
$1,040 |
D/D |
3,060 |
50,532 |
|
- |
|
Tang Kevin C |
Director |
|
2005-09-12 |
4 |
B |
$12.02 |
$938,762 |
I/I |
78,100 |
330,900 |
2.1 |
- |
|
Tang Kevin C |
Director |
|
2005-09-09 |
4 |
B |
$11.94 |
$895,500 |
I/I |
75,000 |
252,800 |
2.1 |
- |
|
Tang Kevin C |
Director |
|
2005-09-08 |
4 |
B |
$11.35 |
$505,963 |
I/I |
44,500 |
6,300 |
2.1 |
- |
|
Bolognesi Dani P |
Chief Scientific Officer |
|
2005-08-29 |
4 |
AS |
$11.30 |
$34,578 |
D/D |
(3,060) |
47,472 |
|
- |
|
372 Records found
|
|
Page 13 of 15 |
|
|